ssODN-mediated In-Frame Deletion With CRISPR/Cas9 to Restore the FVIII Function in Hemophilia a Patient-Derived iPSCs and ECs
Molecular Therapy - Nucleic Acids - United States
doi 10.1016/j.omtn.2019.05.019
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2019
Authors
Publisher
Elsevier BV